Navigation Links
Coronary rehabilitation programs in Europe are underused
Date:6/19/2012

Large proportions of European coronary patients are not benefitting from cardiac rehabilitation services, according to results of the third EUROASPIRE survey published today in the European Journal of Preventive Cardiology.(1) Yet despite the evidence that cardiac rehabilitation is very effective for patients with coronary heart disease, this latest study shows that services in Europe are much underused, with poor referral and a low participation rate.

"There is still considerable potential for cardiac rehabilitation programmes to further reduce the risk of fatal and non-fatal cardiovascular events," say the investigators.

The survey, the biggest in Europe on the secondary prevention of heart disease, showed that less than half (44.8%) of all patients with coronary heart disease (CHD) were advised to follow a rehabilitation programme, but only one-third (36.5%) took part in some form of cardiac rehabilitation. Yet, of those who were advised to attend a programme, four-fifths agreed and did so.

The EUROASPIRE survey, conducted on behalf of the European Society of Cardiology (ESC), analysed medical records and interviewed almost 9000 patients with CHD in 22 countries of Europe. Much variation between countries was found, with highest rehabilitation attendance reported in Lithuania and Ireland, the lowest in Turkey, Cyprus and Russia, and virtually no attendance in Greece and Spain. "These differences are most likely to reflect the heterogeneity of healthcare systems and the availability of cardiac rehabilitation services in some regions of Europe," said the authors.

  • In France 32.4% of CHD patients were advised to attend rehabilitation, and of those advised 90% attended
  • In Germany 56.6% were advised, and 91.1% attended
  • In Italy 51.5% were advised, and 88.7% attended
  • In the UK 43.0% were advised, and 80.6 attended
  • In Spain 3% were advised and < 1% attended

The study also found that patients who had coronary artery bypass surgery were more likely to be offered and attend rehabilitation programmes than those in other diagnostic categories. Smokers, older patients and those with lower educational attainment were also less likely to attend.

As background to the report the authors note that cardiac rehabilitation is recommended by the European Society of Cardiology, the American Heart Association and the American College of Cardiology in the treatment of patients with CHD. It is a cost-effective intervention following an acute coronary event and improves prognosis by reducing recurrent hospitalisation and health care costs, while prolonging life. Indeed, cardiac rehabilitation compares favourably in terms of cost per life year saved with other well-established interventions such as percutaneous coronary interventions or coronary artery bypass surgery.

Investigator Dr Kornelia Kotseva from the National Heart & Lung Institute in London described the results as a major cause for concern. "There is an urgent need to raise the standard of secondary prevention," she said.

EUROASPIRE III is the third survey of the series and was carried out in patients from 76 coronary care centres in Europe. Consecutive patients with a diagnosis of CHD were identified, and interviewed and examined at least six months after their coronary event. Earlier reports have shown that many coronary patients do not achieve lifestyle, risk factor and therapeutic targets for cardiovascular disease prevention as set out in the guidelines. There were wide variations in risk-factor prevalence and use of cardioprotective drug therapies between countries.(2,3)

A comparison between the 13 countries which participated in both the EUROASPIRE II and III surveys showed that the proportion of patients advised to follow a cardiac rehabilitation programme increased from 44.5 to 55.7%, and that the participation rate also increased from 38.0 to 46.1%. It was also shown in EUROASPIRE III that those patients attending a cardiac rehabilitation programme smoked less (with higher smoking cessation rates), and had significantly better total cholesterol control and higher use of cardoprotective medications than found in EUROASPIRE II.

"Although these results are encouraging," said Dr Kotseva, "there is still considerable potential for cardiac rehabilitation programmes to further reduce the risk of fatal and non-fatal cardiovascular events. Many patients referred to and participating to a cardiac rehabilitation programme do not achieve the lifestyle and risk factor target.

"To achieve the clinical benefits of a prevention programme, we need to integrate professional lifestyle interventions with effective risk factor management and evidence-based drug therapies appropriately adapted to the medical, cultural and economic setting of a country. The challenge is to engage and motivate cardiologists, physicians and health professionals to routinely practice high quality preventive cardiology in a health care system which invests in prevention."

Today, cardiac rehabilitation has evolved from supervised exercise sessions and return-to-work training in patients recovering from heart attack or cardiac surgery into more comprehensive programmes which include health education on smoking, diet and physical activity, risk-factor management (control of blood pressure, cholesterol levels and diabetes), and the use of prophylactic drug therapies. The World Health Organisation describes cardiac rehabilitation as "the sum of activities required to influence favourably the underlying cause of the disease, as well as the best possible physical, mental and social conditions, so that they may, by their own efforts preserve or resume when lost, as normal a place as possible in the community".(4)


'/>"/>
Contact: ESC Press Office
press@escardio.org
33-492-948-627
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. Rutgers leads effort to replicate care management programs in 4 U.S. cities
2. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
3. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
4. U.S. Bests Canada, Europe in Drug Approvals
5. Life expectancy and healthy life years in the European Union, 2008-2010
6. Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA ... does not obey the rules Congress has directed the CBO to follow. The CBO ... reform would restore. Yet, it estimates a reduction in employer-based coverage due to the ...
(Date:3/24/2017)... Diego, Calif. (PRWEB) , ... March 24, 2017 ... ... has raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... the instant demand for the product – with nearly 2,000 consumers (and counting) ...
(Date:3/24/2017)... ... 2017 , ... Viewers who like to educate themselves on current issues and ... services, and societal issues tend to appreciate and love the "Informed" series, hosted by ... running events for causes around the world. , Running for charity has ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council ... programs. The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements ... quality in the U.S. It argues that this higher bar should be set by ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 ... providing high-quality and cost-effective drug development and ... pharmaceutical and biotechnology industry, announced today the ... ShangPharma will be consolidating the Contract ... (CMO) under Shanghai ChemPartner. These entities include ...
(Date:3/24/2017)... Research and Markets has announced the addition ... - 2035" report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics ... the growing market of deep learning solutions within the healthcare domain. ... emerged as a novel solution to generate relevant insights from medical ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
Breaking Medicine Technology: